ロード中...
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
OBJECTIVE: Rapamycin analogs have reproducible but modest efficacy in endometrial cancer (EC). Identification of molecular biomarkers that predict benefit could guide clinical development. METHODS: Fixed primary tissue and whole blood were collected prospectively from patients enrolled on GOG 248. D...
保存先:
| 出版年: | Gynecol Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5119517/ https://ncbi.nlm.nih.gov/pubmed/27016228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.02.025 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|